Document is current
Any future updates will be listed below
-
Authors
Riestra, Maria Rodrigo
Pillay, Bethany A.
Willemsen, Mathijs
Kienapfel, Verena
Ehlers, Lisa
Delafontaine, Selket
Pinton, Antoine
Wouters, Marjon
Hombrouck, Anneleen
Sauer, Kate
Bossuyt, Xavier
Voet, Arnout
Soenen, Stefaan J.
Conde, Cecilia Dominguez
Bucciol, Giorgia
Boztug, Kaan
Humblet-Baron, Stephanie
Touzart, Aurore
Rieux-Laucat, Frédéric
Notarangelo, Luigi D.
Moens, Leen
Meyts, Isabelle https://orcid.org/0000-0003-1214-0302
-
Funding
Funding for this research was provided by:
UZ Leuven Klinische Onderzoeksraad
European Society for Immunodeficiencies
Fonds Wetenschappelijk Onderzoek (Senior Clinical Researcher)
Onderzoeksraad, KU Leuven (C16/18/007)
- License Information
-
More Information
Article History
Received: 6 October 2023
Accepted: 3 November 2023
First Online: 15 December 2023
Declarations
:
: The Ethics Committee of the University Hospitals Leuven (UZLeuven) approved this study (S66910, S63807). The study was performed in compliance with the Declaration of Helsinki for research involving human subjects.
: Written informed consent was obtained from the parents prior to DNA, PBMCs, and fibroblast isolation.
: Informed consent was provided by the parents for the publication of the images in Fig. a and b.
: IM receives funding from CSL Behring and consultancy fees from Boehringer-Ingelheim, unrelated to this submission, paid to KU Leuven.
